Organigram Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Organigram Holdings şirketinin toplam hissedar öz sermayesi CA$271.6M ve toplam borcu CA$155.0K olup, bu da borç-öz sermaye oranını 0.06% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$298.5M ve CA$26.8M dir.

Anahtar bilgiler

0.06%

Borç/özkaynak oranı

CA$155.00k

Borç

Faiz karşılama oranı	n/a
Nakit	CA$33.86m
Eşitlik	CA$271.62m
Toplam yükümlülükler	CA$26.83m
Toplam varlıklar	CA$298.46m

Son finansal sağlık güncellemeleri

Recent updates

Organigram Holdings Inc.'s (TSE:OGI) P/S Is On The Mark

Jun 09

OrganiGram Holdings Inc. (TSE:OGI) Analysts Are Reducing Their Forecasts For This Year

Apr 18

What Did OrganiGram Holdings' (TSE:OGI) CEO Take Home Last Year?

Feb 12

Analysts Are More Bearish On OrganiGram Holdings Inc. (TSE:OGI) Than They Used To Be

Jan 14

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: OGI 'nin kısa vadeli varlıkları ( CA$156.0M ) kısa vadeli yükümlülüklerini ( CA$22.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: OGI şirketinin kısa vadeli varlıkları ( CA$156.0M ) uzun vadeli yükümlülüklerini ( CA$4.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: OGI şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: OGI 'nin borç/öz sermaye oranı son 5 yılda 49.4% seviyesinden 0.06% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: OGI şirketinin mevcut serbest nakit akışına dayanarak yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Tahmini Nakit Akışı: OGI tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Organigram Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Organigram Completes Share Consolidation to Ensure the Company Continues to Comply with Nasdaq Listing Requirements

Organigram Holdings Receives Non-Compliance Notice from Nasdaq

Recent updates

Organigram Holdings Inc., Annual General Meeting, Jan 22, 2025

Organigram Holdings Inc. to Report Q3, 2024 Results on Aug 13, 2024

Organigram Announces Appointment of Craig Harris to Board of Directors

Organigram Holdings Inc. to Report Q2, 2024 Results on May 14, 2024

Organigram Holdings Inc. has completed a Composite Units Offering in the amount of CAD 25.0002 million.

Organigram Holdings Inc. Receives Health Canada’S Final Redetermination on Jolts

Organigram Holdings Inc. to Report Q1, 2024 Results on Feb 13, 2024

Organigram Holdings Inc. Appoints Karina Gehring as Director and Announces Composition of Committees

Organigram Holdings Inc Announces Chief Financial Officer Changes

Organigram Holdings Inc. to Report Q4, 2023 Results on Dec 19, 2023

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. Announces CFO Changes

Organigram Holdings Inc. announced that it expects to receive CAD 124.559674 million in funding from British American Tobacco p.l.c.

Organigram Holdings Inc., Annual General Meeting, Jan 15, 2024

Organigram Holdings Inc. Announces Resignation of Ms. Caroline Ferland as Board Member

Organigram Holdings Inc. Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower

Organigram Relaunches One of Canada's First Cannabis Brands, Trailblazer

Organigram Holdings Inc. Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes

Organigram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

Organigram Holdings Inc. to Report Q3, 2023 Results on Jul 13, 2023

Organigram Completes Share Consolidation to Ensure the Company Continues to Comply with Nasdaq Listing Requirements

New major risk - Shareholder dilution

Organigram Holdings Inc.'s (TSE:OGI) P/S Is On The Mark

Price target decreased by 12% to CA$1.50

Consensus EPS estimates increase from loss to CA$0.0029 profit

Consensus EPS estimates upgraded to CA$0.0012 loss, revenue downgraded

Price target decreased by 16% to CA$1.70

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Organigram Holdings Receives Non-Compliance Notice from Nasdaq

Consensus forecasts updated

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter and Full Year of Fiscal 2023

Price target decreased to CA$2.07

Organigram Holdings Inc. to Report Q1, 2023 Results on Jan 12, 2023

Organigram Holdings Inc., Annual General Meeting, Feb 28, 2023

Price target decreased to CA$2.25

Consensus forecasts updated

Price target decreased to CA$2.30

OrganiGram Holdings Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended August 31, 2022

Organigram Holdings Inc. Launches Holy Mountain to Further Support Its Strong Position in the Dried Flower and Hash Categories

OrganiGram Holdings Inc. to Report Q4, 2022 Results on Nov 28, 2022

High number of new directors

Forecast to breakeven in 2025

Consensus estimates of losses per share improve by 31%

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of Fiscal Year 2022

Price target decreased to CA$2.73

OrganiGram Holdings Inc. to Report Q3, 2022 Results on Jul 14, 2022

Organigram Holdings Inc. Reaches Proposed Settlement

High number of new directors

Consensus EPS estimates fall by 24%

Second quarter 2022 earnings: Revenues in line with analyst expectations

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022

OrganiGram Holdings Inc. to Report Q2, 2022 Results on Apr 12, 2022

No longer forecast to breakeven

Consensus estimates of losses per share improve by 32%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Organigram Holdings Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2022

No longer forecast to breakeven

OrganiGram Holdings Inc. (TSX:OGI) acquired Laurentian Organic Inc. for CAD 35.9 million.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CA$3.59

OrganiGram Holdings Inc. Provides Revenue Guidance for the First Quarter of 2022

Organigram Holdings Inc Announces the Launch of SHRED’ems

Organigram Holdings Inc.Launches Cannabis Innovators Panel

Third quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.51 loss in 3Q 2020)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Fourth Quarter of 2021

Organigram Launches Big Bag o’ Buds Indoor-grown, Strain-specific Dried Flower in 28g Value Format

OrganiGram Holdings Inc. (TSE:OGI) Analysts Are Reducing Their Forecasts For This Year

Second quarter 2021 earnings released: CA$0.28 loss per share (vs CA$0.041 loss in 2Q 2020)

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of 2021

OrganiGram Holdings Inc. announced that it has received CAD 221.0736 million in funding from British American Tobacco p.l.c.

Price target raised to CA$2.88

Organigram Holdings Inc. Launches SHRED Tropic Thunder Jar of J’s (Jar of Joints) and Trailblazer SNAX Milk Chocolate Bars